EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells

Yusuf Saleem Khan iD, Aisha Farhana iD, Mohammed Kuddus iD, Syed Monowar Alam Shahid iD, Abdullah Alsrhani iD, Abuzar Abdulwahab Osman, Ghorashy E Y Mohammed, Muhammad Ikram Ullah iD, Zafar Rasheed

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26209983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yusuf Saleem Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, College of Medicine, University of Hail, Hail 55476, Saudi Arabia. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 2, MicroRNAs, Lung Neoplasms, Receptor for Advanced Glycation End Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Deanship at University of Ha'il - Saudi Arabia, Scientific Research Deanship at University of Hail—Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated microRNA-mediated control of matrix metalloproteinase-2 (MMP-2) plays a pivotal role in lung cancer (LC) progression, though the inflammatory signaling mechanisms governing its regulation remain poorly understood. This study reveals how S100A4-activated RAGE signaling modulates MMP-2 expression through microRNA-125b-5p (miR-125b-5p) in human LC cells. Potential miRNA target genes were computationally predicted using TargetScan algorithms. Functional interaction between miR-125b-5p and MMP-2 3′UTR was experimentally validated through dual-luciferase reporter assays incorporating full-length MMP-2 3′UTR sequence. Further validation was performed through transfection with miRNA inhibitors or mimics. To delineate the underlying mechanisms, key pathways were inhibited using small-molecule antagonists targeting p38-MAPK and NF-κB. Our analysis identified a conserved miR-125b-5p binding site in the MMP-2 3′UTR. In A549 cells, S100A4 induced reciprocal regulation, simultaneously upregulating MMP-2 and downregulating miR-125b-5p, with luciferase assays confirming direct targeting. Pre-miR-125b-5p transfection effectively reduced endogenous MMP-2 levels, while p38-MAPK/NF-κB activation mediated this regulation by suppressing miR-125b-5p consequently elevating MMP-2 expression. These findings were further validated in another human LC cell, SHP-77. These findings provide the first evidence demonstrating that miR-125b-5p directly regulates MMP-2 in LC, establishing S100A4-RAGE⟶p38/NF-κB⟶miR-125b-5p⟶MMP-2 axis as a novel regulatory pathway. The results position miR-125b-5p as a dual-action biomarker and therapeutic target against MMP-2-driven LC metastasis, offering new insights into critical inflammation-to-cancer connections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Metalloproteinase 2MicroRNAsLung NeoplasmsReceptor for Advanced Glycation End ProductsHumansGene Expression Regulation, NeoplasticA549 Cellsp38 Mitogen-Activated Protein KinasesSignal TransductionNF-kappa BCell Line, TumorNF-kappa B p50 Subunit3' Untranslated RegionsTranscription Factor RelA

Stichwörter der Autor:innen

A549 cellsNF-κBRAGES100A4lung cancermatrix metalloproteinase-2miR-125b-5pmicroRNAp38-MAPKpost translational regulation

Substanzen

Matrix Metalloproteinase 2MicroRNAsMIRN125 microRNA, humanp38 Mitogen-Activated Protein KinasesMMP2 protein, humanNF-kappa BNF-kappa B p50 SubunitReceptor for Advanced Glycation End Products3' Untranslated RegionsTranscription Factor RelA

Autor:innen und Institutionen

  • Department of Anatomy, College of Medicine, University of Hail, Hail 55476, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.
  • Department of Biochemistry, College of Medicine, University of Hail, Hail 55476, Saudi Arabia.
  • Department of Pharmacology, College of Medicine, University of Hail, Hail 55476, Saudi Arabia.
  • Department of Pathology, College of Medicine, University of Hail, Hail 55476, Saudi Arabia.
  • Department of Pathology, College of Medicine, Qassim University, P.O. Box 6655, Buraidah 51452, Saudi Arabia.

ORCID-Profile: Yusuf Saleem Khan, Aisha Farhana, Mohammed Kuddus, Syed Monowar Alam Shahid, Abdullah Alsrhani, Muhammad Ikram Ullah

Förderung

  • Scientific Research Deanship at University of Ha'il - Saudi Arabia
  • Scientific Research Deanship at University of Hail—Saudi Arabia

Zitieren

APA

Khan, Y. S., Farhana, A., Kuddus, M., Shahid, S. M. A., Alsrhani, A., Osman, A. A., Mohammed, G. E. Y., Ullah, M. I., & Rasheed, Z. (2025). MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209983

Vancouver

Khan YS, Farhana A, Kuddus M, Shahid SMA, Alsrhani A, Osman AA, et al. MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209983

BibTeX
@article{Khan2025,
  author = {Khan, Yusuf Saleem and Farhana, Aisha and Kuddus, Mohammed and Shahid, Syed Monowar Alam and Alsrhani, Abdullah and Osman, Abuzar Abdulwahab and Mohammed, Ghorashy E Y and Ullah, Muhammad Ikram and Rasheed, Zafar},
  title = {MicroRNA-125b-5p Drives MMP-2 Expression via Activation of RAGE-38MAPK-p65/p50NF-κB Axis: A Novel Mechanism in Human Lung Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26209983}
}
Kostenlos starten →